These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11489241)

  • 21. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 22. Research funding, conflicts of interest, and the meta-methodology of public relations.
    Rampton S; Stauber J
    Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
    [No Abstract]   [Full Text] [Related]  

  • 23. The potential for bias in reporting of industry-sponsored clinical trials.
    Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J
    Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.
    Lexchin J
    Sci Eng Ethics; 2012 Jun; 18(2):247-61. PubMed ID: 21327723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sources of bias in the economic analysis of new drugs.
    Le Pen C
    JAMA; 2000 Mar; 283(11):1423-4. PubMed ID: 10732926
    [No Abstract]   [Full Text] [Related]  

  • 26. Sources of bias in the economic analysis of new drugs.
    Prendergast MM
    JAMA; 2000 Mar; 283(11):1424. PubMed ID: 10732927
    [No Abstract]   [Full Text] [Related]  

  • 27. Sources of bias in the economic analysis of new drugs.
    Rakatansky H
    JAMA; 2000 Mar; 283(11):1424. PubMed ID: 10732928
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceutical industry sponsorship and research outcome and quality: systematic review.
    Lexchin J; Bero LA; Djulbegovic B; Clark O
    BMJ; 2003 May; 326(7400):1167-70. PubMed ID: 12775614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financial conflicts of interest in economic analyses in oncology.
    Jang S; Chae YK; Majhail NS
    Am J Clin Oncol; 2011 Oct; 34(5):524-8. PubMed ID: 21441858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
    Bekelman JE; Li Y; Gross CP
    JAMA; 2003 Jan 22-29; 289(4):454-65. PubMed ID: 12533125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Industry sponsorship and selection of comparators in randomized clinical trials.
    Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
    Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Publication standards for clinical research sponsored by the pharmaceutical industry].
    Rev Panam Salud Publica; 2003 Jul; 14(1):62-6. PubMed ID: 12952617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
    Schott G; Pachl H; Limbach U; Gundert-Remy U; Ludwig WD; Lieb K
    Dtsch Arztebl Int; 2010 Apr; 107(16):279-85. PubMed ID: 20467553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.
    Safer DJ
    J Nerv Ment Dis; 2002 Sep; 190(9):583-92. PubMed ID: 12357091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest.
    Rose SL; Highland J; Karafa MT; Joffe S
    JAMA Intern Med; 2017 Mar; 177(3):344-350. PubMed ID: 28114624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis.
    Chartres N; Fabbri A; Bero LA
    JAMA Intern Med; 2016 Dec; 176(12):1769-1777. PubMed ID: 27802480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. US doctors earn speaking and consulting fees from drug companies that sponsor their research.
    McCarthy M
    BMJ; 2014 Mar; 348():g2410. PubMed ID: 24677695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.